Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells

International Journal of Pharmaceutics

Volumn 406, Issue 1-2, 2011, Pages 128-134

  Ulbrich, Karsten ^a   Michaelis, Martin ^b   Rothweiler, Florian ^b   Knobloch, Thomas ^a   Sithisarn, Patchima ^b   Cinatl, Jindrich ^b   Kreuter, Jörg ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Cancer targeting; Folate receptor; Folic acid; Human serum albumin (HSA); Nanoparticles

Indexed keywords

FOLIC ACID; GLUTARALDEHYDE; HUMAN SERUM ALBUMIN; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL VIABILITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; COVALENT BOND; CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG TUMOR LEVEL; FIBROBLAST; FLOW CYTOMETRY; GEL PERMEATION CHROMATOGRAPHY; GLIOBLASTOMA; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; SPECTROFLUOROMETRY; TUMOR CELL; ZETA POTENTIAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; CHROMATOGRAPHY, GEL; DRUG CARRIERS; DRUG STABILITY; FIBROBLASTS; FLOW CYTOMETRY; FOLIC ACID; HUMANS; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PARTICLE SIZE; RATS; SERUM ALBUMIN; SPECTROMETRY, FLUORESCENCE; SURFACE PROPERTIES;

EID: 79951578754     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.12.023     Document Type: Article

References (39)

1. A.P. Alberola, and J.O. Radler The defined presentation of nanoparticles to cells and their surface controlled uptake Biomaterials 30 2009 3766 3770
2. Y. Bae, W.D. Jang, N. Nishiyama, S. Fukushima, and K. Kataoka Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery Mol. Biosyst. 1 2005 242 250 (Pubitemid 41442434)
3. G. Barratt Colloidal drug carriers: achievements and perspectives Cell Mol. Life Sci. 60 2003 21 37 (Pubitemid 36223115)
4. J. Cinatl Jr., J Cinatl, H. Rabenau, H.O. Gumbel, B. Kornhuber, and H.W. Doerr In vitro inhibition of human cytomegalovirus replication by desferrioxamine Antivir. Res. 25 1994 73 77 (Pubitemid 24270366)
5. G. Ciofani, V. Raffa, A. Menciassi, and A. Cuschieri Folate functionalized boron nitride nanotubes and their selective uptake by glioblastoma multiforme cells: Implications for their use as boron carriers in clinical boron neutron capture therapy Nanoscale Res. Lett. 4 2008 113 121
6. F. Dosio, S. Arpicco, B. Stella, P. Brusa, and L. Cattel Folate-mediated targeting of albumin conjugates of paclitaxel obtained through a heterogeneous phase system Int. J. Pharm. 382 2009 117 123
7. H. Elnakat, and M. Ratnam Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy Adv. Drug Deliv. Rev. 56 2004 1067 1084 (Pubitemid 38496508)
8. F. Esmaeili, M.H. Ghahremani, S.N. Ostad, F. Atyabi, M. Seyedabadi, M.R. Malekshahi, M. Amini, and R. Dinarvand Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate J. Drug Target. 16 2008 415 423 (Pubitemid 351935739)
9. C. Feng, T. Wang, R. Tang, J. Wang, H. Long, X. Gao, and S. Tang Silencing of the MYCN gene by siRNA delivered by folate receptor-targeted liposomes in LA-N-5 cells Pediatr. Surg. Int. 26 2010 1185 1191
10. J. Gao, K. Chen, R. Xie, J. Xie, S. Lee, Z. Cheng, X. Peng, and X. Chen Ultrasmall near-infrared non-cadmium quantum dots for in vivo tumor imaging Small 6 2009 256 261
11. Y. Hattori, L. Shi, W. Ding, K. Koga, K. Kawano, M. Hakoshima, and Y. Maitani Novel irinotecan-loaded liposome using phytic acid with high therapeutic efficacy for colon tumors J. Controlled Release 136 2009 30 37
12. E. Heister, C. Lamprecht, V. Neves, C. Tîlmaciu, L. Datas, E. Flahaut, B. Soula, P. Hinterdorfer, H.M. Coley, S.R. Silva, and J. McFadden Higher dispersion efficacy of functionalized carbon nanotubes in chemical and biological environments ACS Nano 4 2009 2615 2626
13. T. Hekmatara, C. Bernreuther, A.S. Khalansky, A. Theisen, J. Weissenberger, S. Gelperina, J. Kreuter, and M. Glatzel Efficient systemic therapy of rat glioblastoma by nanoparticle-bound doxorubicin is due to antiangiogenic effects Clin. Neuropathol. 28 2009 153 164
14. R. Kotchetkov, P.H. Driever, J. Cinatl, M. Michaelis, J. Karaskova, R. Blaheta, J.A. Squire, A. Von Deimling, J. Moog, and J. Cinatl Jr. Increased malignant behavior in neuroblastoma cells with acquired multi-drug resistance does not depend on P-gp expression Int. J. Oncol. 27 2005 1029 1037
15. J.F. Kukowska-Latallo, K.A. Candido, Z. Cao, S.S. Nigavekar, I.J. Majoros, T.P. Thomas, L.P. Balogh, M.K. Khan, and J.R. Baker Jr. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer Cancer Res. 65 2005 5317 5324 (Pubitemid 40827344)
16. K. Langer, C. Coester, C. Weber, H. von Briesen, and J. Kreuter Preparation of avidin-labeled protein nanoparticles as carriers for biotinylated peptide nucleic acid Eur. J. Pharm. Biopharm. 49 2000 303 307 (Pubitemid 30229880)
17. C.P. Leamon Folate-targeted drug strategies for the treatment of cancer Curr. Opin. Investig. Drugs 9 2008 1277 1286
18. Y. Li, X.R. Qi, Y. Maitani, and T. Nagai PEG-PLA diblock copolymer micelle-like nanoparticles as all-trans-retinoic acid carrier: in vitro and in vivo characterizations Nanotechnology 20 2009 55106
19. P.X. Ma Biomimetic materials for tissue engineering Adv. Drug Deliv. Rev. 60 2008 184 198 (Pubitemid 350245692)
20. H Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Controlled Release 65 2000 271 284 (Pubitemid 30122932)
21. J.M. Maris, M.D. Hogarty, R. Bagatell, and S.L. Cohn Neuroblastoma Lancet 369 2007 2106 2120 (Pubitemid 46935947)
22. S. Markert, S. Lassmann, B. Gabriel, M. Klar, M. Werner, G. Gitsch, F. Kratz, and A. Hasenburg Alpha-folate receptor expression in epithelial ovarian carcinoma and non-neoplastic ovarian tissue Anticancer Res. 28 2008 3567 3572
23. M. Michaelis, K. Langer, S.C. Arnold, N. Hinsch, F. Rothweiler, H.E. Deubzer, O. Witt, K. Langer, H.W. Doerr, W.S. Wels, and J. Cinatl Jr. Pharmacological activity of DTPA linked to protein-based drug carrier systems Biochem. Biophys. Res. Commun. 323 2004 1236 1240 (Pubitemid 39296557)
24. Y. Nie, Z. Zhang, L. Li, K. Luo, H. Ding, and Z. Gu Synthesis, characterization and transfection of a novel folate-targeted multipolymeric nanoparticles for gene delivery J. Mater. Sci.-Mater. Med. 20 2009 1849 1857
25. E.K. Park, S.B. Lee, and Y.M. Lee Preparation and characterization of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs Biomaterials 26 2005 1053 1061 (Pubitemid 39208991)
26. N. Parker, M.J. Turk, E. Westrick, J.D. Lewis, P.S. Low, and C.P. Leamon Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay Anal. Biochem. 338 2005 284 293 (Pubitemid 40312593)
27. M. Prabaharan, J.J. Grailer, S. Pilla, D.A. Steeber, and S. Gong Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(l-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery Biomaterials 30 2009 3009 3019
28. I. Steinhauser, B. Spankuch, K. Strebhardt, and K. Langer Trastuzumab-modified nanoparticles: optimisation of preparation and uptake in cancer cells Biomaterials 27 2006 4975 4983 (Pubitemid 43866920)
29. S.C. Steiniger, J. Kreuter, A.S. Khalansky, I.N. Skidan, A.I. Bobruskin, Z.S. Smirnova, S.E. Severin, R. Uhl, M. Kock, K.D. Geiger, and S.E. Gelperina Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles Int. J. Cancer 109 2004 759 767 (Pubitemid 38405625)
30. J. Sudimack, and R.J. Lee Targeted drug delivery via the folate receptor Adv. Drug Deliv. Rev. 41 2000 147 162 (Pubitemid 30122955)
31. T.P. Thomas, R. Shukla, A. Kotlyar, J. Kukowska-Latallo, and J.R. Baker Jr. Dendrimer-based tumor cell targeting of fibroblast growth factor-1 Bioorg. Med. Chem. Lett. 20 2010 700 703
32. G. Tosi, L. Costantino, B. Ruozi, F. Forni, and M.A. Vandelli Polymeric nanoparticles for the drug delivery to the central nervous system Expert Opin. Drug Deliv. 5 2008 155 174 (Pubitemid 351308309)
33. K. Ulbrich, T. Hekmatara, E. Herbert, and J. Kreuter Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB) Eur. J. Pharm. Biopharm. 71 2009 251 256
34. K. Ulbrich, T. Knobloch, and J. Kreuter Targeting the insulin receptor: nanoparticles for drug delivery across the blood-brain barrier (BBB) J. Drug Target. 19 2011 125 132
35. J. Vandervoort, and A. Ludwig Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study Int. J. Pharm. 238 2002 77 92 (Pubitemid 34457877)
36. H. Wartlick, K. Michaelis, S. Balthasar, K. Strebhardt, J. Kreuter, and K. Langer Highly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cells J. Drug Target. 12 2004 461 471 (Pubitemid 39562430)
37. C. Weber, J. Kreuter, and K. Langer Desolvation process and surface characteristics of HSA-nanoparticles Int. J. Pharm. 196 2000 197 200 (Pubitemid 30105742)
38. Y. Wei, N.R. Jana, S.J. Tan, and J.Y. Ying Surface coating directed cellular delivery of TAT-functionalized quantum dots Bioconjug. Chem. 20 2009 1752 1758
39. P.Y. Wen, and S. Kesari Malignant gliomas in adults New Engl. J. Med. 359 2008 492 507